Vol 43, No 1 (2012)
Experts’ Guidelines
Published online: 2012-01-01

open access

Page views 173
Article views/downloads 4118
Get Citation

Connect on Social Media

Connect on Social Media

Strategy of management in Epstein-Barr virus infections in hematology, oncology and transplantology. Guidelines of polish Federation of Bone marrow transplant centers

Jan Styczyński12, Lidia Gil3, Sławomira Kyrcz-Krzemień4, Beata Piątkowska-Jakubas5, Krzysztof Kałwak6, Jacek Wachowiak7, Agnieszka Wierzbowska8, Agnieszka Tomaszewska9, Katarzyna Drabko10, Tomasz Czerw11, Mieczysław Komarnicki3
DOI: 10.1016/S0001-5814(12)31004-9
Acta Haematol Pol 2012;43(1):48-53.

Abstract

A significant increase of knowledge on EBV-related post-transplant lymphoproliferative disorder has been observed recently. This reflects increase in number of transplants from alternative donors, development of diagnostics based on quantitative EBV-DNA-emia and new therapeutic possibilities including monoclonal anti-CD20 antibodies or cytotoxic anti-EBV specific T lymphocytes (CTL).

On October 15, 2011, in Poznan, working group of Polish Federation of Bone marrow transplant centers, has prepared guidelines on management in prophylaxis, diagnostics and therapy in EBV infections and reactivations in hematology, oncology and stem cell transplantology. in this report, specificity of Polish centers was taken into account

Article available in PDF format

View PDF (Polish) Download PDF file